LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase designed specifically to meet the needs of diagnostic kit developers.
7 March, 2019, Hoddesdon, UK - LGC, Biosearch Technologies proudly introduces RapiDxFire™ Thermostable RT, a truly thermostable reverse transcriptase (RT) designed specifically to meet the needs of diagnostic kit developers.
This reverse transcriptase has a temperature optimum from 55 - 80 °C, improving reaction specificity and allowing synthesis from diverse RNA templates. It is also fast, with a reaction time of five minutes or less, and recommended for targets under 1 kb. Its extended stability at room temperature provides automation deck compatibility, and the enzyme is available in a lyophilization-ready, Triton™ X-100 free format.
Mark Dearden, VP Strategy and Marketing, LGC, Biosearch Technologies, said, “LGC has a tremendous business partnering with the world’s leading Molecular Diagnostic kit developers. The launch of our new RapiDxFire™ Thermostable RT extends our capabilities for these partners, delivering a novel enzyme that have superior specificity, speed, and room temperature stability. It’s a great example of how LGC continues to deliver on its strategy to be a leading provider of mission critical tools that enable molecular diagnostic development.”
Biosearch Technologies, the complete genomics portfolio from LGC, operates from cGMP and ISO 13485:2016 certified production facilities.
Contact your local rep for information on this enzyme or Biosearch Technologies’ line of kits and reagents for molecular diagnostics product development.
Notes for editors
About LGC
LGC is an international leader in the extended life sciences sector, including human healthcare, agri-food & the environment. LGC provides a comprehensive range of reference materials, proficiency testing schemes, genomics reagents and instrumentation, as well as research and measurement services. Its scientific tools and solutions enable organisations to advance research, develop new products and form an essential part of their quality and compliance procedures.
LGC’s 2,600 employees include internationally-recognised scientists who are experts in their field. Headquartered in London, it operates out of 19 countries worldwide and is extensively accredited to quality standards such as GMP, GLP, ISO 13485, ISO 17034, ISO 17043, ISO/IEC 17025 and ISO 9001.
LGC has been home to the UK Government Chemist for more than 100 years and is the UK National Measurement Laboratory and Designated Institute for chemical and bio measurement. LGC has been privately-owned since 1996 and has diversified through internal investment and acquisition to be an international leader in its chosen niche markets. LGC is now owned by funds affiliated with KKR.
For more information, please visit www.lgcgroup.com
Media contact details
LGC
Julian Quigley
Media Relations & Social Media Manager
+44 (0)20 8943 8491
Julian.quigley@lgcgroup.com
